CLINICAL_TRIALS
trial_result
· 2013-09-12
Clinical Trial Update: Zydena on Cognitive Function of Alzheimer's Disease Patients [Phase 3]
Summary
A Phase 3 clinical trial evaluating Zydena for cognitive function in Alzheimer's disease is in progress. The current status of the trial is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Samsung Medical Center | Conditions: Alzheimer's Disease | Phase 3 | Status: UNKNOWN